Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type  | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| General Motors Company | General Motors | motor vehicles | motor vehicle safety violation | 2017 | MULTI-AG | $120,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | $71,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
| Celgene Corp. | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $62,000,000 |
| Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
| Healthpoint Ltd. | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $28,000,000 | ||
| Inspire Pharmaceuticals | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $181,000,000 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
| Pfizer | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
| Purdue Pharma | Purdue Pharma | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | $19,500,000 |
| Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
| BP | BP | oil and gas | oil spill | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,900,000,000 |
| MOEX Offshore 2007 LLC | Mitsui | diversified | oil spill | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
| ACE Group Holdings, Inc. | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $4,500,000 |
| ACE, Ltd | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $80,000,000 |
| Akzo Nobel Inc. | Carlyle Group | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Alpharma, Inc. | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| American International Group, Inc. | American International Group | financial services | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $12,500,000 |
| Apple Inc. | Apple Inc. | electrical and electronic equipment | price-fixing or anti-competitive practices | 2014 | MULTI-AG | $450,000,000 |
| AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $170,000,000 |
| Aventis Animal Nutrition | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $20,721,300 | ||
| Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
| Bank of America | Bank of America | financial services | price-fixing or anti-competitive practices | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $67,000,000 |
| Barr Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
| BASF Corporation | BASF | chemicals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $62,258,250 |
| Bausch & Lomb | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
| Bertelsmann Music Group Inc. | Sony | electrical and electronic equipment | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $27,775,000 |
| Bioproducts Incorporated | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 | ||
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
| Chimei Innolux Corp. | Chi Mei Corporation | chemicals | price-fixing or anti-competitive practices | 2011 | MULTI-AG | $110,273,318 |
| Chinook Global Limited | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 | ||
| Chubb | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $17,000,000 |
| Chunghwa Picture Tubes Ltd. | Tatung | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | MULTI-AG | $5,305,105 |
| CIBA Vision | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
| E*Trade | Morgan Stanley | financial services | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $100,000 |
| Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
| Elpida Memory Inc. | Micron Technology | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $4,259,948 |
| EMI Music Distribution | Sony | electrical and electronic equipment | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $15,000,000 |
| Encore Paper Co. | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $300,000 | ||
| Endo International plc | Endo International | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
| Epson | Seiko Group | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | MULTI-AG | $2,850,000 |
| Evonik Degussa GmbH | Evonik Industries | chemicals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Ferring B.V. | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,800,000 | ||
| First Group, plc | FirstGroup | miscellaneous services | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $1,100,000 |
| Fort James Corp. | Koch Industries | diversified | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $300,000 |
| GE Funding Capital Market Services, Inc. | price-fixing or anti-competitive practices | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $34,250,000 | ||
| Geneva Pharmaceuticals | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
| Hachette Book Group Inc. | price-fixing or anti-competitive practices | 2013 | MULTI-AG | $34,791,666 | ||
| HannStar Display Corporation | HannStar Display | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | MULTI-AG | $25,650,000 |
| HarperCollins Publishers LLC | News Corp. | media | price-fixing or anti-competitive practices | 2013 | MULTI-AG | $22,471,666 |
| Healthcare Research and Development Institute, LLC | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $150,000 | ||
| Herman Miller, Inc. | MillerKnoll Inc. | miscellaneous manufacturing | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $750,000 |
| Hitachi, Ltd. | Hitachi | diversified | price-fixing or anti-competitive practices | 2011 | MULTI-AG | $38,977,224 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
| Holtzbrinck Publishers LLC dba MacMillan | price-fixing or anti-competitive practices | 2014 | MULTI-AG | $26,250,000 | ||
| Hynix Semiconductor, Inc. | SK Hynix | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $49,971,842 |
| Infineon Technologies A.G. | Infineon Technologies | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $29,113,776 |
| Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | price-fixing or anti-competitive practices | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $75,000,000 |
| Kimberly-Clark Corp. | Kimberly-Clark | household and personal care products | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $300,000 |
| LG Display Co., Ltd. | LG | diversified | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $380,000,000 |
| Lonza AG | Lonza | chemicals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Marcal Paper Mills Co. | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $300,000 | ||
| Marsh & McLennan Companies, Inc. | Marsh & McLennan | financial services | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $850,000,000 |
| Marsh and McLennan | Marsh & McLennan | financial services | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $7,000,000 |
| Merck KGaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Micron Technology, Inc. | Micron Technology | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $66,774,984 |
| Mitsubishi Tanabe Pharma Corporation | Mitsubishi Chemical | chemicals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Mosel-Vitelic Corp. | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $2,778,900 | ||
| Musicland Stores Corp. | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $2,000,000 | ||
| Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
| National Football League | price-fixing or anti-competitive practices | 2016 | MULTI-AG | $100,000 | ||
| Natixis Funding Corp. | price-fixing or anti-competitive practices | 2016 | MULTI-AG | $29,950,000 | ||
| NEC Electronics America, Inc. | NEC Corp. | information technology | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $20,277,350 |
| Nepera, Inc. | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 | ||
| New Times Media | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $375,000 | ||
| Nine West Group Inc. | Premier Brands Group Holdings | apparel | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $34,000,000 |
| Penguin Group (USA) Inc. | Bertelsmann | media | price-fixing or anti-competitive practices | 2014 | MULTI-AG | $90,000,000 |
| Perrigo Company | Perrigo | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| Salton Inc. | Spectrum Brands Holdings | housewares and home furnishings | price-fixing or anti-competitive practices | 2002 | MULTI-AG | $8,200,000 |
| Samsung Electronics, Co., Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2011 | MULTI-AG | $240,000,000 |
| Samsung Semiconductor, Inc. and Samsung Electronics Company, Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $90,000,000 |
| Sharp Corporation | Foxconn Technology Group (Hon Hai Precision Industry Company) | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | MULTI-AG | $115,500,000 |
| Simon and Schuster Inc. | KKR & Co. | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2013 | MULTI-AG | $20,641,666 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
| Societe Generale | Societe Generale | financial services | price-fixing or anti-competitive practices | 2016 | MULTI-AG | $26,750,000 |
